Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Check-Cap Ltd. (MBAI)

NCM · Diagnostics & Research

$1.05-0.02 (-1.87%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$8.1M
P/E (TTM)
1.59
EPS
$0.66
Div Yield
52W Range
$0.59–$3.92
Beta
0.79

Company overview

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Peers in Diagnostics & Research

All in industry →

Recent press releases

March 2026

4 months ago6-KHealthcare

Check-Cap Ltd — 6-K Filing

MBAICheck-Cap Ltd

# 📋 What This Document Is This is a **6-K filing**, which is a "current report" public companies use to announce major news to investors. Think of it like a press release officially filed with the SEC. This specific filing updates the market on two key things: 1) a major customer expanding its use

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Check-Cap Ltd. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
12,437 sh-42.5%
1,311 sh-79.7%
7,990 sh+1075.0%
500 sh● NEW
1,500 sh0.0%

People at Check-Cap Ltd.

All people →

Quarterly financials

Full financials →
Revenue trend
12/24
NI -$25.1M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.